Pregnancy, Pediatrics and HIV Infection:  Guidelines for Your Practice

Bibliography


REFERENCES

 

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173-1180.
2. Centers for Disease Control. Success in implementing public health service guidelines to reduce perinatal HIV transmission -- Louisiana, Michigan, New Jersey, and South Carolina, 1993, 1995, and 1996. MMWR. 1998;47:688-691.
3. Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet. 1999.354:1084-1089.
4. Smith ME and the US Nucleoside Safety Review Working Group. Ongoing nucleoside safety review of HIV-exposed children in US studies. Second Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. September 1-6, 1999, Montreal, Canada (Abstract 096).
5. Lorenzi P, Spicher VM, Laubereau B, et al. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS. 1998;12:241-247.
6. Centers for Disease Control Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1 Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. June 16, 2002. AIDS Info Webpage
7. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med. 1998. 339:1409-1414.
8. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet. 1999. 353:773-780.
9. Saba J, on behalf of the PETRA Trial Study Team. Interim analysis of early efficacy of three short ZDV/3TC combination regimens to prevent mother-to-child transmission of HIV-1: the PETRA trial. Sixth Conference on Retroviruses and Opportunistic Infections. Chicago, Ill, January 1999 (Abstract S-7).
10. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795-802.
11. Bardeguez, A., Shiapiro, D., Sorenson, LM, et al. effect of cessation of zidovudine profhylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr Hum Retroviral, 2003. 32(20170-181).
 

Back to Course Listing | AMNJ Online CME